丹纳赫公司(DHR)今日盘中股价大跌6.63%,引发了广泛关注。
经查阅相关新闻报道发现,这一暴跌的主因来自该公司发布的2024年第四季度业绩不佳,尤其是每股利润不及分析师预期。报告显示,丹纳赫上季度每股实现收益2.14美元,低于预期的2.16美元,未能达标。
分析指出,导致利润不及预期的重要原因是,丹纳赫在生物技术和制药领域遇冷,客户需求明显疲软。特别是小型生物科技公司和制药企业在药物开发方面持谨慎支出态度,对该公司相关产品和服务的需求大幅下降。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.